Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects

NCT02453672 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
119
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samsung Bioepis Co., Ltd.